Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Using more low-cost and generic drugs could save Medicare Part D a lot of money.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

A young dog with an enlarged prostate and cysts improved significantly after treatment and surgery.

Post-finasteride syndrome causes various symptoms in men using finasteride, with no known cure.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

A man had a rare stroke possibly due to taking finasteride, which might have increased his hormone levels causing a blood clot. His memory loss didn't fully recover even after stopping the medication.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Patients follow treatment well, but many change medicines; good information helps compliance.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Saw palmetto is not proven to improve urinary flow, prostate size, or hair loss.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.